Published October, 2016
By Alister C. Ward
Publisher: Springer (Birkhauser Verlag AG)
Rating:
Availability: Available

This volume, which includes contributions from leading scientists and clinicians in the field, provides definitive, state-of-the-art information on STAT inhibitors in a biological and clinical context.

---

Published October, 2016
By Patricia A. Ganz
Publisher: Springer (Springer International Publishing AG)
Rating:
Availability: Available

In collaboration with the Breast Cancer Research Foundation (BCRF), this timely volume provides a comprehensive review on all areas of breast cancer survivorship research, highlighting research that is underway or in development.

---

Published October, 2016
By Heinz U. Lemke and Leonard Berliner
Publisher: Springer (Springer International Publishing AG)
Rating:
Availability: Available

An IT System for Personalized Medicine (ITS-PM) for HCC will provide the means to identify and determine the relative value of the wide number of variables, including clinical assessment of the patient -- functional status, liver function, degree of cirrhosis, and comorbidities;

---

Published October, 2016
By Nima Rezaei
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating:
Availability: Available

It clearly explains their immunology and describes novel immunotherapy for specific cancers, including pediatric solid tumors, hematologic malignancies, gastrointestinal tumors, skin cancers, bone and connective tissue tumors, central nervous system tumors, lung cancers, genitourinary tract tumors and breast cancers.

---

Published October, 2016
By Mieczyslaw Pokorski
Publisher: Springer (Springer International Publishing AG)
Rating:
Availability: Available

The book blends basic and clinical research on respiratory carcinogensis. The focus is on the search for novel molecular markers, derived from easily accessible tissues in clinical settings, such as the serum or bronchoalveolar lavage fluid, which could help diagnose cancer at an early stage and have a prognostic therapeutic value.

---

Published October, 2016
By Wei Wu and Hani Choudhry
Publisher: Springer (Springer International Publishing AG)
Rating:
Availability: Available

Latest generation sequencing revolutionizes the fields of cancer research and oncology. This follow-up volume focuses more extensively on single cell sequencing of cancer and trials in drug resistance. A reasonable cancer treatment plan and potential cure is more optimistic now with the unfolding of the cancer genome.

---

Published October, 2016
By Benjamin Bonavida and Salem Chouaib
Publisher: Springer (Springer International Publishing AG)
Rating:
Availability: Available

This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis.

---

Published October, 2016
By Alexey Larionov
Publisher: Springer (Springer International Publishing AG)
Rating:
Availability: Available

Aromatase Inhibitors (AIs) treat postmenopausal estrogen receptor positive tumours, which constitute the majority of breast cancer patients. The second section provides the detailed mechanisms of resistance to AIs, while the third section explores prediction of resistance and potential strategies to overcome resistance.

---

Published October, 2016
By Georg Stuebinger
Publisher: Springer
Rating:
Availability: Available

In 2012, about 14 m cancer cases and 8.2 m cancerdeaths appeared worldwide whereby cancer represents one of the most frequent causes of death accounting for approximately 13% with a continuously rising number.

---

Published October, 2016
By Benjamin Bonavida and Rama Shanker Verma
Publisher: Springer (Springer International Publishing AG)
Rating:
Availability: Available

This book will be a guide to understanding resistance against targeted therapeutic approaches for cancer using immunotoxins. As well, it includes an in-depth description of the molecular and cellular mechanisms involved in cancer resistance and several novel methods to overcome resistance.

---